Cervix Cancer, Human Papilloma Virus, Vaginal Cancer, Vulvar Cancer
Conditions
Brief summary
The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.
Interventions
OTHERControl
A standardized handout on HPV and vaccine education will be given
OTHERIntervention
A video about HPV and vaccines on a tablet provided by a research assistant
Sponsors
University of Oklahoma
Radhika Gogoi
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 18 and older * Patients with an ICD9 diagnosis of cervical/vaginal/vulvar cancer or dysplasia receiving care at Karmanos Cancer Institute or OU Health Stephenson Cancer Center
Exclusion criteria
* Patients who are recorded in the EHR as requesting to be removed from research * Non-English speakers * Any cognitive disability that prevents informed consent * Any individual recruited in previous phases of the Study will be excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Participation Rate | Up to 6 weeks | The Ratio of the number of participants to the number of patients asked to join the clinical trial |
| Survey Completion Rate | Up to 6 Weeks | The Ratio of the number of participants who complete the survey to the number of participants overall. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in intention to discuss HPV vaccination | Up to 6 weeks | Changes from pre to post/follow up on intervention survey |
| Change in Health Literacy | Up to 6 weeks | Changes in knowledge of HPV virus and prevention from pre to post/follow up survey |
| Change in social norms and behaviors | Up to 6 weeks | Changes in social norms and behavioral control measures from pre and post/follow-up survey |
| Change in Stigma | Up to 6 weeks | Changes in stigma measures in pre and post/follow up surveys |
Countries
United States
Outcome results
None listed